If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,006.00    -54.00 (-5.09%)
Bid:
1,006.00
Ask:
1,010.00
Spread: 4.00 (0.398%)
Market Cap: £144.14b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Capital increase timeline

27 Oct 2020 17:59

RNS Number : 3972D
Banco Santander S.A.
27 October 2020
 

 

 

Banco Santander, S.A. ("Banco Santander" or the "Bank" or "Santander"), pursuant to the provisions of the Spanish Securities Market Act (Ley del Mercado de Valores), hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

At the general meeting held today, shareholders passed a resolution to increase share capital against reserves (hereinafter, the 'Capital Increase'). If approved by the Bank's Executive Committee, the Capital Increase will be used to pay out approximately 0.10 euros per share in the form of newly issued shares as announced on 29 July 2020. The timeline for the Capital Increase is as follows:

· 12 November 2020. Execution of the Capital Increase and announcement of the number of rights required to receive one share.

· 13 November 2020 (23:59 hours CET). Reference date to participate in the Capital Increase (last trading date). Those who acquired their shares in the Bank by this date (inclusive) and appear as shareholders in the registries of Iberclear at 23:59 CET on 17 November 2020, will be entitled to take part in the Capital Increase.

· 16 November 2020. Start of the rights trading period. Santander shares will trade ex-coupon (ex-date).

· 30 November 2020. End of the rights trading period.

· 4-10 December 2020. Procedures for registering the Capital Increase and admitting new shares to trading on Spanish securities markets.

· 11 December 2020. Start of ordinary trading of the new shares on Spanish securities markets, subject to required authorisation.[1] Shareholders receive their new shares.

 

Boadilla del Monte (Madrid), 27 October, 2020

 

 

[1] Estimated date. The Bank shall also request that the new shares be admitted to trading on any foreign securities markets where it is listed.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDGRUDDGGR
Date   Source Headline
7th May 20254:58 pmRNSSantander informs of the MREL determined by SRB
7th May 202511:09 amRNSBuyback programme: transactions 29Apr-6May
6th May 20257:00 amRNSPresentation to analysts about sale of San Polska
6th May 20257:00 amRNSSantander announces sale of 49%of Santander Polska
6th May 20257:00 amRNSAnalysts meeting announcement
30th Apr 202512:41 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNS1Q 2025 Results report & analyst presentation
30th Apr 20257:00 amRNS1Q 2025 Results Press Release
29th Apr 202511:11 amRNSBuyback programme: Transactions 23-28Apr
28th Apr 20251:56 pmRNSSantander statement
23rd Apr 202511:59 amRNS1st Quarter 2025 Results Notice
23rd Apr 202511:11 amRNSBuyback programme: transactions 11-22Apr
11th Apr 202511:13 amRNSBuyback programme: transactions 3-10Apr
4th Apr 20253:09 pmRNS2025 AGM - Resolutions
4th Apr 20257:08 amRNSSantander expects growth & 2025 targets reaffirmed
3rd Apr 202511:13 amRNSBuyback programme: transactions 27Mar-2Apr
31st Mar 20254:07 pmRNSTotal Voting Rights
27th Mar 202511:15 amRNSTransaction in Own Shares
20th Mar 202511:10 amRNSBuyback programme: transactions 13Mar-19Mar
17th Mar 20255:31 pmRNSDirector/PDMR Shareholding
14th Mar 20251:27 pmRNSDirector/PDMR Shareholding
14th Mar 20251:22 pmRNSDirector/PDMR Shareholding
13th Mar 202511:06 amRNSBuyback programme: transactions 6 Mar -12 Mar
6th Mar 202511:14 amRNSBuyback programme: transactions 27 Feb- 5 Mar
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20256:23 pmRNSDirector/PDMR Shareholding
28th Feb 20256:19 pmRNSDirector/PDMR Shareholding
28th Feb 20256:14 pmRNSDirector/PDMR Shareholding
28th Feb 20256:08 pmRNSDirector/PDMR Shareholding
28th Feb 202510:52 amRNSTotal Voting Rights
28th Feb 202510:51 amRNSNotice of AGM
28th Feb 202510:15 amRNS2024 UK Annual Report
27th Feb 202511:12 amRNSBuyback programme: transactions 20Feb-26Feb
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDividend declaration & agreement to call 2025 AGM
20th Feb 202511:12 amRNSBuyback programme: transactions 13Feb-19Feb
19th Feb 20255:46 pmRNSDirector/PDMR Shareholding
14th Feb 20251:10 pmRNSReplaces Invitation to purchase certain instrument
13th Feb 202512:00 pmRNSInvitation to purchase certain instruments
13th Feb 202511:18 amRNSBuyback programme: transactions 6Feb-12Feb
12th Feb 20253:43 pmRNSRating granted by Fitch Ratings
7th Feb 20251:49 pmRNSDirector/PDMR Shareholding
7th Feb 20251:48 pmRNSDirector/PDMR Shareholding
6th Feb 20258:00 amRNSInvitation to purchase certain instruments
5th Feb 20257:00 amRNS2024 Results - Press release
5th Feb 20257:00 amRNS2024 Financial report & Earnings presentation
5th Feb 20257:00 amRNSCommencement of a program to repurchase own shares
31st Jan 20251:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.